Back

The Implantable System That Restores Hemodynamic Stability After Spinal Cord Injury

Phillips, A. A.; Gandhi, A. P.; Hankov, N.; Hernandez-Charpak, S. D.; Rimok, J.; Incognito, A.; Nijland, A. E. J.; D'Ercole, M.; Watrin, A.; Berney, M.; Damianaki, A.; Dumont, G.; Macellari, N.; De Herde, L.; Baaklini, E.; Smith, D.; Miller, R.; Lee, J.; Intering, N.; Ledoux, J.-B.; Ordonnez, J. G.; Newton, T.; Meliado, E. F.; Duguet, L.; Jacquet, C.; Bole-Feysot, L.; Rieger, M.; Gelenitis, K.; Dumeny, Y.; Caban, M.; Ganty, D.; Paoles, E.; Baumgartner, T.; Clinical Study Team, ; Onward Team, ; Harte, C.; Sasportes, C. D.; Romo, P.; Vouga, T.; Fasola, J.; Ravier, J.; Gautier, M.; Merlos, F.;

2024-05-10 cardiovascular medicine
10.1101/2024.05.10.24306826 medRxiv
Show abstract

A spinal cord injury (SCI) causes immediate and sustained hemodynamic instability that threatens neurological recovery and impacts quality of life. Here, we establish the clinical burden of chronic hypotensive complications due to SCI in 1,479 participants, and expose the ineffective treatment of these complications with conservative measures. To address this clinical burden, we developed a purpose-built implantable system based on biomimetic epidural electrical stimulation (EES) of the spinal cord that immediately triggered robust pressor responses. The system durably reduced the severity of hypotensive complications in people with SCI, removed the necessity for conservative treatments, improved quality of life, and enabled engagement in activities of daily living. Central to the development of this therapy was the head-to-head demonstration in the same participants that EES must target the last three thoracic segments, and not the lumbosacral segments, to achieve the safe and effective regulation of blood pressure in people with SCI. These findings in 14 participants establish a path for a pivotal device trial that evaluates the safety and efficacy of EES to treat the underappreciated, treatment-resistant hypotensive complications due to SCI.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 2%
23.0%
2
Biomaterials
78 papers in training set
Top 0.1%
19.0%
3
Advanced Healthcare Materials
71 papers in training set
Top 0.3%
7.3%
4
Circulation
66 papers in training set
Top 0.5%
7.3%
50% of probability mass above
5
Nature Biomedical Engineering
42 papers in training set
Top 0.1%
5.0%
6
eLife
5422 papers in training set
Top 21%
4.1%
7
Advanced Science
249 papers in training set
Top 8%
2.4%
8
JACC: Clinical Electrophysiology
11 papers in training set
Top 0.2%
1.9%
9
Neuron
282 papers in training set
Top 5%
1.9%
10
Nature Medicine
117 papers in training set
Top 2%
1.7%
11
Nature
575 papers in training set
Top 11%
1.5%
12
Science Bulletin
22 papers in training set
Top 0.4%
1.4%
13
Science Advances
1098 papers in training set
Top 21%
1.4%
14
iScience
1063 papers in training set
Top 21%
1.3%
15
Cell Genomics
162 papers in training set
Top 4%
1.3%
16
Nature Genetics
240 papers in training set
Top 5%
1.3%
17
Nature Neuroscience
216 papers in training set
Top 5%
1.1%
18
Cell
370 papers in training set
Top 14%
1.0%
19
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
20
Science Translational Medicine
111 papers in training set
Top 5%
0.8%
21
Nature Machine Intelligence
61 papers in training set
Top 3%
0.8%
22
Scientific Reports
3102 papers in training set
Top 74%
0.8%
23
npj Digital Medicine
97 papers in training set
Top 3%
0.8%
24
PLOS ONE
4510 papers in training set
Top 73%
0.5%
25
PLOS Medicine
98 papers in training set
Top 6%
0.5%
26
ACS Nano
99 papers in training set
Top 5%
0.5%